Press release
Navigating the Future: Blood Cancer Drugs Market Trends and Forecast Insights, 2025 Edition
Blood Cancer Drugs Market
Blood Cancer Drugs Market Size Growth Forecast: What to Expect by 2025?
The market size for blood cancer medication has markedly increased in the past few years. From $74.69 billion in 2024, it is projected to rise to $79.6 billion in 2025 with a compound annual growth rate (CAGR) of 6.6%. The historic growth can be linked to progress in research and development, an aging population, heightened awareness, early detection, and regulatory approvals.
How Will the Blood Cancer Drugs Market Size Evolve and Grow by 2029?
Expectations are high for robust expansion in the blood cancer drugs market in the coming years. The market is anticipated to swell up to $104.37 billion by 2029 at a compound annual growth rate (CAGR) of 7.0%. This growth during the forecast period is driven by factors such as rising disease incidence, emerging markets, and supportive care. The period is also predicted to witness trends like investments in research and development, combination therapies, biomarker identification, advances in immunotherapy, and personalized medicine.
View the full report here:
https://www.thebusinessresearchcompany.com/report/blood-cancer-drugs-global-market-report
What Drivers Are Propelling the Growth of Blood Cancer Drugs Market Forward?
The worldwide rise in mortality rates and prevalence of blood cancer is propelling the growth of the blood cancer drugs market. Various forms of blood cancer, including lymphoma, leukemia, myeloma, and others, present differing risk factors, some of which can be controlled or prevented with drug therapies, while some may result in death. For example, a report from Bristol-Myers Squibb Company in November 2022 predicts that over 1.85 million new cases of blood cancer will be diagnosed globally in 2040, including 918,872 lymphoma cases, 656,345 leukemia cases, and 275,047 myeloma cases. Additionally, the report projects that by 2040, the global death toll from blood cancer will reach approximately 1,100,000. This rising death rate and growing prevalence of blood cancer globally are key factors fueling the expansion of the blood cancer drugs market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2587&type=smp
What Are the Key Trends Driving Blood Cancer Drugs Market Growth?
Leading firms in the blood cancer drugs market are concentrating their efforts on creating novel drugs and securing FDA approval to stay competitive. FDA approval means the official permission given by the United States Food and Drug Administration (FDA) for a medicinal product to be legally sold and marketed in the US. For example, Bristol Myers Squibb, an American pharmaceutical company, received FDA approval in March 2024 for its pioneering CAR T-cell therapy for adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that is either relapsed or refractory. This swift approval permits the therapy's use in patients who have already undergone at least two previous treatments, including a Bruton tyrosine kinase inhibitor and a B-cell lymphoma 2 inhibitor. According to the TRANSCEND CLL 004 trial, Breyanzi, the treatment in question, showed a complete response rate of 20% and a median duration of response in 35.3 months among those who responded.
What Are the Key Segments in the Blood Cancer Drugs Market?
The blood cancer drugs market covered in this report is segmented -
1) By Blood Cancer Type: Leukemia, Lymphoma
2) By Drugs: Rituxan Or Mabthera (Rituximab), Gleevec Or Glivec (Imatinib), Revlimid (Lenalidomide), Velcade (Bortezomib), Tasigna (Nilotinib), Pomalyst (Pomalidomide), Vidaza (Azacitidine), Kyprolis (Carfilzomib), Adcetris (Brentuximab Vedotin), Other Drugs
3) By Treatment Approaches: Key Findings, Chemotherapeutic, MAbs/Targeted Therapies, Immunotherapeutic
Subsegments:
1) By Leukemia: Acute Lymphoblastic Leukemia (ALL), Chronic Lymphocytic Leukemia (CLL), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), Other Types of Leukemia
2) By Lymphoma: Hodgkin Lymphoma, Non-Hodgkin Lymphoma (NHL), Burkitt Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Other Types of Lymphoma
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=2587&type=smp
Who Are the Key Players Shaping the Blood Cancer Drugs Market's Competitive Landscape?
Major companies operating in the blood cancer drugs market include Amgen Inc., AstraZeneca PLC, Bayer AG, Eli Lilly and Company Inc., Johnson & Johnson, Novartis AG, Pfizer Inc., AbbVie Inc., Takeda Pharmaceutical Company Limited, F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, Astellas Pharma Inc., Roche Holding AG, Merck & Co. Inc., Gilead Sciences Inc., Sanofi S.A., Eisai Co. Ltd., Jazz Pharmaceuticals plc, Kyowa Kirin Co. Ltd., Menarini Group, Millennium Pharmaceuticals Inc., Mundipharma International Limited, Mylan N.V., Ono Pharmaceutical Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Pharmacyclics LLC, Regeneron Pharmaceuticals Inc., Seattle Genetics Inc., Servier Laboratories, Shire plc, Spectrum Pharmaceuticals Inc., Taiho Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Tolero Pharmaceuticals Inc., UCB S.A., Vertex Pharmaceuticals Incorporated
What Geographic Markets Are Powering Growth in the Blood Cancer Drugs Market?
North America was the largest region in the blood cancer drugs market in 2024. Middle East is expected to be the fastest-growing region in the blood cancer drugs market during the forecast period. The regions covered in the blood cancer drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2587
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Navigating the Future: Blood Cancer Drugs Market Trends and Forecast Insights, 2025 Edition here
News-ID: 4183899 • Views: …
More Releases from The Business Research Company
Chemotherapy's Role In Driving The Growth Of Xerostomia Therapeutics Market: A K …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Xerostomia Therapeutics Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for xerostomia therapeutics has been on a steady upward trend in the past few years. The market, which was valued at $2.14 billion in 2024, is anticipated to reach $2.24 billion in…
Emerging Trends to Reshape the Aripiprazole Market: Extended-Release Therapies E …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Aripiprazole Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Over the past few years, the aripiprazole market has seen substantial growth. This market is predicted to expand from $7.04 billion in 2024 to $7.58 billion in 2025, recording a compound annual growth rate (CAGR) of…
Emerging Trends to Drive Calcineurin Inhibitors Market Growth at 7.8% CAGR Throu …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Calcineurin Inhibitors Market Size Growth Forecast: What to Expect by 2025?
The market size for calcineurin inhibitors has significantly expanded in the past few years, showing prospective growth from $8.84 billion in 2024 to $9.49 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.4%. Elements contributing…
2025-2034 Phenobarbital Market Evolution: Disruptions, Innovations, and Untapped …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Phenobarbital Market Through 2025?
Over the past few years, the phenobarbital market has been experiencing consistent growth. It is projected to expand from a value of $1.47 billion in 2024 to approximately $1.54 billion in 2025, achieving a compound annual growth rate…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
